Image (23feea8d Ed70 456c 8426 E50332cea9c0 159 1)
Doxazosin Mesylate Tablet
Product Images NDC 29300-353
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 29300-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (23feea8d Ed70 456c 8426 E50332cea9c0 174 2)
Chemical Structure (E2406e8e 68c2 49dc 9e15 6170f3fffa03 01)
Chemical structure of doxazosin mesylate, showing its molecular arrangement including aromatic rings, heterocyclic rings, and methanesulfonic acid (mesylate) component.*
Image (E2406e8e 68c2 49dc 9e15 6170f3fffa03 02)
A table and bar graph summarizing effectiveness data of Doxazosin Mesylate tablets versus placebo in three placebo-controlled trials. The table shows symptom scores and maximum flow rate measurements at baseline and mean change for placebo and different doses (4 mg, 8 mg) of Doxazosin. The bar graph depicts maximum flow rate changes in Study 2 for placebo and Doxazosin 4 mg and 8 mg groups, showing positive changes with the drug doses compared to placebo.*
Image (E2406e8e 68c2 49dc 9e15 6170f3fffa03 03)
Two line graphs depicting clinical trial results for Doxazosin Mesylate tablets. The left graph shows the mean change in total symptom score from baseline over 14 weeks, with Doxazosin showing a greater decrease compared to placebo. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline over 14 weeks, with Doxazosin demonstrating a higher increase versus placebo. Both charts include statistical significance markers.*
Doxazosin Tablets Usp, 1 mg (E2406e8e 68c2 49dc 9e15 6170f3fffa03 04)
Doxazosin Tablets, USP 1 mg oral tablets label displaying a bottle containing 100 tablets. The label includes dosage instructions, storage conditions, a barcode, and highlights that the product is prescription-only. Manufactured by Unichem Laboratories Ltd. and labeled for Unichem Pharmaceuticals (USA), Inc.*
Doxazosin Tablets Usp, 2 mg (E2406e8e 68c2 49dc 9e15 6170f3fffa03 05)
Label for Doxazosin Tablets, USP 2 mg, oral tablets supplied in a package of 100 tablets. The label shows the active ingredient doxazosin mesylate equivalent to 2 mg doxazosin per tablet. It includes storage instructions and warnings to keep drugs out of reach of children. Manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc.*
Doxazosin Tablets Usp, 4 mg (E2406e8e 68c2 49dc 9e15 6170f3fffa03 06)
Label for Doxazosin Mesylate Tablets, USP 4 mg, oral tablets in a bottle containing 100 tablets. Labeled for prescription use only. The label shows storage instructions, manufacturer information for Unichem Laboratories Ltd. in India, and Unichem Pharmaceuticals (USA), Inc. in New Jersey, USA. A barcode is also visible.*
Doxazosin Tablets Usp, 8 mg (E2406e8e 68c2 49dc 9e15 6170f3fffa03 07)
Label for Doxazosin Tablets, USP 8 mg, oral tablets in a package of 100. The label shows the product name, strength, and NDC number 29300-354-01. It is manufactured by Unichem Laboratories Ltd. (India) and Unichem Pharmaceuticals (USA), Inc. Storage instructions and a barcode are also visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
